how should hypomethylating agents be used in combination therapy?
Published 5 years ago • 64 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
7:03
can hypomethylating agents plus venetoclax replace chemotherapy induction for patients with aml?
-
5:08
combining hypomethylating agents in aml
-
18:29
aml treatment challenges who, when, and how
-
3:02
what are hypomethylating agents? #aml
-
4:19
intervening on time: how hypomethylating agents can prevent transition to aml
-
52:20
acute myeloid leukemia: incorporating novel treatment approaches into clinical pathways
-
3:14
hypomethylating agents in mds and aml
-
1:40
oral combination of hmas venetoclax in unfit or elderly patients with aml
-
2:04
the impact of cytogenetics on treatment decisions in aml
-
19:37
2021 west oncology app | treatment options for elderly aml/mds patients
-
3:25
treatment approaches for elderly/unfit patients with aml ineligible for intensive chemotherapy
-
4:23
how would you treat newly diagnosed induction-eligible patients with acute myeloid leukemia?
-
4:55
checkpoint inhibitor combination approaches for aml/mds: an update
-
19:40
targeted therapies in aml
-
3:59
treatment cessation using venetoclax-based therapy for older patients with aml
-
4:10
bcl-2 inhibitors with hypomethylating agents in aml
-
3:59
overview of new combination therapies in acute myeloid leukemia (aml)
-
9:24
how could new treatment combinations improve outcomes in tp53 mutant aml?
-
1:20
dr. donnellan on developing combinations in aml